Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Ahlman

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2020
Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I-Related Plexiform NeurofibromasLauren H Boal, John Glod, Melissa Spencer, et al.
Clinical Cardiology|April 2, 2022
Inflammation, coronary plaque progression, and statin use: A secondary analysis of the Risk Stratification with Image Guidance of HMG CoA Reductase Inhibitor Therapy (RIGHT) studyColin Scott, Sundus S Lateef, Christin G Hong, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 25, 2023
Anakinra-Associated Systemic AmyloidosisSara Alehashemi, Surendra Dasari, Anvitha Metpally, et al.
Journal for Immunotherapy of Cancer|October 26, 2024
<i>CRLF2</i>-rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapySara K Silbert, Samantha Scanlon, Hao-Wei Wang, et al.
Blood|May 23, 2022
CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CARHaneen Shalabi, Haiying Qin, Angela Su, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2020
Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I-Related Plexiform NeurofibromasLauren H Boal, John Glod, Melissa Spencer, et al.
Clinical Cardiology|April 2, 2022
Inflammation, coronary plaque progression, and statin use: A secondary analysis of the Risk Stratification with Image Guidance of HMG CoA Reductase Inhibitor Therapy (RIGHT) studyColin Scott, Sundus S Lateef, Christin G Hong, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 25, 2023
Anakinra-Associated Systemic AmyloidosisSara Alehashemi, Surendra Dasari, Anvitha Metpally, et al.
Journal for Immunotherapy of Cancer|October 26, 2024
<i>CRLF2</i>-rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapySara K Silbert, Samantha Scanlon, Hao-Wei Wang, et al.
Blood|May 23, 2022
CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CARHaneen Shalabi, Haiying Qin, Angela Su, et al.
Pageof 2